Article Details
Retrieved on: 2021-05-17 15:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Alexion recorded just over $5.1 billion in net sales from those two drugs last year, with Soliris accounting for about 80% of the total. Dive Insight: Alexion ...
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here